Clearstead Advisors, LLC Omeros Corp Transaction History
Clearstead Advisors, LLC
- $7.4 Billion
- Q3 2025
A detailed history of Clearstead Advisors, LLC transactions in Omeros Corp stock. As of the latest transaction made, Clearstead Advisors, LLC holds 26 shares of OMER stock, worth $180. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26Holding current value
$180% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding OMER
# of Institutions
146Shares Held
30.6MCall Options Held
419KPut Options Held
2.03M-
Ingalls & Snyder LLC New York, NY4.11MShares$28.6 Million0.55% of portfolio
-
Black Rock Inc. New York, NY4.1MShares$28.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.35MShares$23.3 Million0.0% of portfolio
-
Stifel Financial Corp St. Louis, MO1.81MShares$12.6 Million0.01% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY1.65MShares$11.5 Million0.0% of portfolio
About OMEROS CORP
- Ticker OMER
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,730,000
- Market Cap $437M
- Description
- Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...